ClassID:

96761

C07K9/003 - CPC Classification

Classification description:

Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure Peptides being substituted by heterocyclic radicals, e.g. bleomycin, phleomycin

Recent Application in this class:
#1
20250179122
2025-06-05

Telomerase Reverse Transcriptase (TERT) Expression Enhancing Compounds and Methods for Using the Same

#2
20240254163
2024-08-01

HEMIASTERLIN DERIVATIVES FOR CONJUGATION AND THERAPY

#3
20230174578
2023-06-08

CHIP SURFACE LINKER AND PREPARATION METHOD AND USE THEREFOR

#4
20220056079
2022-02-24

Third generation tubulysin analogues and process of preparation thereof

#5
20210261611
2021-08-26

HEMIASTERLIN DERIVATIVES FOR CONJUGATION AND THERAPY

#6
20210198314
2021-07-01

Hemiasterlin derivatives for conjugation and therapy

#7
20210069340
2021-03-11

ANTIFOLATE CONJUGATES FOR TREATING INFLAMMATION

#8
20210024581
2021-01-28

CONJUGATES CONTAINING HYDROPHILIC SPACER LINKERS

#9
20210015888
2021-01-21

Supramolecular glycosaminoglycans

#10
20210008159
2021-01-14

Peptides with anti-cancer activity

#11
20200109430
2020-04-09

COMPOSITIONS FOR IN SITU LABELING OF BACTERIAL CELL WALLS WITH FLUOROPHORES AND METHODS OF USE THEREOF

#12
20190083570
2019-03-21

Peptides with anti-cancer activity

#13
20190024135
2019-01-24

Compositions for in situ labeling of bacterial cell walls with fluorophores and methods of use thereof

#14
20180339060
2018-11-29

Bifunctional cytotoxic agents

#15
20180207285
2018-07-26

Cell penetrating peptide inhibitors of p53-MDM2 interaction

#16
20180125924
2018-05-10

Supramolecular gylcosaminoglycans

#17
20170151340
2017-06-01

Conjugates containing hydrophilic spacer linkers

#18
20160257709
2016-09-08

Hemiasterlin derivatives for conjugation and therapy

#19
20160168183
2016-06-16

Conjugates Containing Hydrophilic Spacer Linkers

#20
20160075746
2016-03-17

Tailoring multivalent interactions of biopolymers with a polyproline scaffold

#21
20150209445
2015-07-30

Bifunctional cytotoxic agents

#22
20150191763
2015-07-09

COMPOSITIONS FOR IN SITU LABELING OF BACTERIAL CELL WALLS WITH FLUOROPHORES AND METHODS OF USE THEREOF

#23
20150080318
2015-03-19

Compositions for the Treatment or Prophylaxis of Viral Infections

#24
20130338096
2013-12-19

Compositions for the treatment or prophylaxis of viral infections

#25
20100323973
2010-12-23

Conjugates containing hydrophilic spacer linkers

#26
20100256087
2010-10-07

Compositions for the treatment or prophylaxis of viral infections

#27
20100041584
2010-02-18

Gem difluorinated C-glycopeptides, their preparation and their use for the preservation of biological materials and/or in cryosugery

#28
20090054623
2009-02-26

Lipo-Conjugation of Peptides

#29
20080260691
2008-10-23

Prodrugs of Ribavirin with Improved Hepatic Delivery

#30
20080214648
2008-09-04

Hiv Prodrugs Cleavable by Cd26

#31
20080108557
2008-05-08

Modified Proteins

#32
20070293442
2007-12-20

Antithrombotic compound

#33
20070275900
2007-11-29

Prodrugs cleavable by CD26

#34
20070197465
2007-08-23

Hyaluronic acid-methotrexate conjugate

#35
20070173636
2007-07-26

Method for preparing polyfunctionalized peptides and/or proteins via native chemical ligation

#36
20070060541
2007-03-15

2' and 3'-nucleoside prodrugs for treating Flaviviridae infections

#37
20070060505
2007-03-15

2' and 3'-nucleoside prodrugs for treating Flaviviridae infections

#38
20070060504
2007-03-15

2' and 3'-nucleoside prodrugs for treating Flaviviridae infections

#39
20070060503
2007-03-15

2' and 3'-nucleoside prodrugs for treating Flaviviridae infections

#40
20070060498
2007-03-15

2′ and 3′-nucleoside prodrugs for treating infections

#41
20070042990
2007-02-22

2' and 3'-nucleoside prodrugs for treating Flaviviridae infections

#42
20070037735
2007-02-15

2' and 3'-nucleoside prodrugs for treating Flaviviridae infections

#43
20070015905
2007-01-18

2′ and 3′-nucleoside prodrugs for treating infections

#44
20060281897
2006-12-14

Potentialization of the activation of high molecular weight prodrugs

#45
16879075
2025-09-02

Telomerase reverse transcriptase (TERT) expression enhancing compounds and methods for using the same